Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

247 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cystic fibrosis, lung infections, and a human tracheal antimicrobial peptide (hTAP).
Ko YH, Delannoy M, Pedersen PL. Ko YH, et al. Among authors: pedersen pl. FEBS Lett. 1997 Mar 24;405(2):200-8. doi: 10.1016/s0014-5793(97)00189-0. FEBS Lett. 1997. PMID: 9089291
Cystic fibrosis: a brief look at some highlights of a decade of research focused on elucidating and correcting the molecular basis of the disease.
Ko YH, Pedersen PL. Ko YH, et al. Among authors: pedersen pl. J Bioenerg Biomembr. 2001 Dec;33(6):513-21. doi: 10.1023/a:1012831322753. J Bioenerg Biomembr. 2001. PMID: 11804193 Review.
Modeling of nucleotide binding domains of ABC transporter proteins based on a F1-ATPase/recA topology: structural model of the nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator (CFTR).
Bianchet MA, Ko YH, Amzel LM, Pedersen PL. Bianchet MA, et al. Among authors: pedersen pl. J Bioenerg Biomembr. 1997 Oct;29(5):503-24. doi: 10.1023/a:1022443209010. J Bioenerg Biomembr. 1997. PMID: 9511935
., and Pedersen, P.L. (1995) J. Biol. Chem. 268, 24330-24338], providing support for the model. In contrast, the second nucleotide binding fold is predicted at best to be a weak ATPase as the glutamic acid residue is replaced with a glutamine. ...
., and Pedersen, P.L. (1995) J. Biol. Chem. 268, 24330-24338], providing support for the model. In contrast, the second nucleotide bi …
Frontiers in research on cystic fibrosis: understanding its molecular and chemical basis and relationship to the pathogenesis of the disease.
Ko YH, Pedersen PL. Ko YH, et al. Among authors: pedersen pl. J Bioenerg Biomembr. 1997 Oct;29(5):417-27. doi: 10.1023/a:1022402105375. J Bioenerg Biomembr. 1997. PMID: 9511927 Review.
Cystic fibrosis transmembrane conductance regulator: the first nucleotide binding fold targets the membrane with retention of its ATP binding function.
Ko YH, Delannoy M, Pedersen PL. Ko YH, et al. Among authors: pedersen pl. Biochemistry. 1997 Apr 22;36(16):5053-64. doi: 10.1021/bi9630265. Biochemistry. 1997. PMID: 9125527
Regulation of the mitochondrial ATP synthase/ATPase complex: cDNA cloning, sequence, overexpression, and secondary structural characterization of a functional protein inhibitor.
Lebowitz MS, Pedersen PL. Lebowitz MS, et al. Among authors: pedersen pl. Arch Biochem Biophys. 1993 Feb 15;301(1):64-70. doi: 10.1006/abbi.1993.1115. Arch Biochem Biophys. 1993. PMID: 8442667
The three-dimensional structure of rat liver mitochodria F1-ATPase: X-ray diffraction studies.
Bianchet M, Medjahed D, Hulihen J, Pedersen PL, Amzel LM. Bianchet M, et al. Among authors: pedersen pl. Biochim Biophys Acta. 1994 Aug 30;1187(2):163-4. doi: 10.1016/0005-2728(94)90103-1. Biochim Biophys Acta. 1994. PMID: 8075110 No abstract available.
Nucleotide domains in transport ATPases: structure-function and relationship to disease.
Thomas PJ, Ko YH, Shenbagamurthi P, Pedersen PL. Thomas PJ, et al. Among authors: pedersen pl. Soc Gen Physiol Ser. 1995;50:17-28. Soc Gen Physiol Ser. 1995. PMID: 7676321 Review. No abstract available.
Glucose catabolism in cancer cells. Isolation, sequence, and activity of the promoter for type II hexokinase.
Mathupala SP, Rempel A, Pedersen PL. Mathupala SP, et al. Among authors: pedersen pl. J Biol Chem. 1995 Jul 14;270(28):16918-25. doi: 10.1074/jbc.270.28.16918. J Biol Chem. 1995. PMID: 7622509
The first nucleotide binding fold of the cystic fibrosis transmembrane conductance regulator can function as an active ATPase.
Ko YH, Pedersen PL. Ko YH, et al. Among authors: pedersen pl. J Biol Chem. 1995 Sep 22;270(38):22093-6. doi: 10.1074/jbc.270.38.22093. J Biol Chem. 1995. PMID: 7545672
247 results
Jump to page
Feedback